THIS CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH ...THIS CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
-
実験情報
-
実験
実験
手法: X線回折 / 使用した結晶の数: 1
-
試料調製
結晶
マシュー密度: 2.36 Å3/Da / 溶媒含有率: 47.92 %
結晶化
温度: 277 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 7.9 詳細: 0.2000M (NH4)2HPO4, 20.0000% PEG-3350, No Buffer pH 7.9, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K
モノクロメーター: Double Crystal Si(111) / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray
放射波長
波長: 0.9789 Å / 相対比: 1
反射
解像度: 2.15→29.921 Å / Num. obs: 63504 / % possible obs: 99.9 % / 冗長度: 3.6 % / Biso Wilson estimate: 26.801 Å2 / Rmerge(I) obs: 0.147 / Χ2: 1.263 / Net I/σ(I): 9.204
反射 シェル
解像度 (Å)
冗長度 (%)
Rmerge(I) obs
Num. unique all
Χ2
Diffraction-ID
% possible all
2.1-2.15
3.6
0.805
4791
1.38
1
99.9
2.15-2.21
3.7
0.69
4796
1.191
1
100
2.21-2.28
3.6
0.623
4802
1.363
1
99.8
2.28-2.35
3.7
0.526
4809
1.202
1
99.9
2.35-2.43
3.7
0.433
4828
1.203
1
100
2.43-2.53
3.7
0.343
4812
1.175
1
100
2.53-2.65
3.7
0.282
4848
1.134
1
100
2.65-2.79
3.7
0.228
4828
1.209
1
100
2.79-2.96
3.7
0.177
4834
1.117
1
99.9
2.96-3.19
3.6
0.135
4885
1.185
1
100
3.19-3.51
3.6
0.102
4869
1.379
1
99.9
3.51-4.02
3.6
0.079
4919
1.456
1
100
4.02-5.06
3.5
0.06
4947
1.282
1
99.8
5.06-29.921
3.6
0.055
5115
1.415
1
98.8
-
位相決定
位相決定
手法: 単波長異常分散
-
解析
ソフトウェア
名称
バージョン
分類
NB
REFMAC
5.2.0019
精密化
PHENIX
精密化
SHELX
位相決定
MolProbity
3beta29
モデル構築
SCALEPACK
データスケーリング
PDB_EXTRACT
3.006
データ抽出
HKL-2000
データ削減
SHELXD
位相決定
autoSHARP
位相決定
精密化
構造決定の手法: 単波長異常分散 / 解像度: 2.15→29.921 Å / Cor.coef. Fo:Fc: 0.956 / Cor.coef. Fo:Fc free: 0.922 / Occupancy max: 1 / Occupancy min: 0.5 / SU B: 10.934 / SU ML: 0.149 / TLS residual ADP flag: LIKELY RESIDUAL / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.238 / ESU R Free: 0.202 立体化学のターゲット値: MAXIMUM LIKELIHOOD WITH PHASES 詳細: 1.HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2.ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 3.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN ...詳細: 1.HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2.ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 3.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4.RESIDUE LYS312 IN BOTH CHAINS HAS BEEN MODIFIED BY COVALENT MODIFICATION WITH PLP VIA A SCHIFF BASE FORMATION BETWEEN THE LYSINE AND THE PLP AND IS MODELED AS LLP. 5.1,2-ETHANEDIOL (EDO) MOLECULES FROM THE CRYOPROTECTANT HAVE BEEN MODELED IN THE SOLVENT STRUCTURE.
Rfactor
反射数
%反射
Selection details
Rfree
0.238
3199
5.1 %
RANDOM
Rwork
0.177
-
-
-
obs
0.18
63132
99.25 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK